-
Mashup Score: 14Challenges in ageing persons with haemophilia - 12 day(s) ago
As treatments for individuals with inherited bleeding disorders improve, life expectancy increases and is approaching that of the normal population. Concomitant with this we are now seeing the probl…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4The importance and evolution of bleeding disorder registries - 12 day(s) ago
Registries are excellent sources of data to address questions that are typically not evaluated in randomized clinical trials, including natural history, disease prevalence, treatment approaches and …
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Abstract. The US Food and Drug Administration (FDA)’s authorization of etranacogene dezaparvovec (Hemgenix) is a significant milestone, constituting not on
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22The Application of AI to the Care of Thrombocytopenia - 20 day(s) ago
A video from Drew Provan (as part of XIV Eurasian Hematology-Oncology Congress – EHOC 2023), posted on Feb 14, 2024.
Source: www.vumedi.comCategories: General Medicine News, Hem/OncsTweet-
Great lecture on Vumedi where a hematologist explains Artificial Intelligence and its application to medicine. He concludes by discussing the AI application to the field of thrombocytopenia. https://t.co/Qzh86QgrzW It is free to view but you have to register first. Thank you for… https://t.co/GiDpbCxdaz https://t.co/Yg54hwVWMR
-
-
Mashup Score: 70Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies - 21 day(s) ago
Age-dependent effects on plasma VWF levels in type 1 VWD define distinct subgroups with important differences in underlying pathogenesis.Low VWF does not c
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 96Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial - 21 day(s) ago
Subcutaneous emicizumab administered from birth has the potential to reduce the risk of ICH and joint bleeds before damage occurs.Primary analysis of the H
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Emicizumab (#Hemlibra) is highly effective in children less than 1 year of age with #hemophilia A. The HAVEN-7 trial results are published in @BloodJournal. PDF behind pay wall. https://t.co/kRHWnb74eO Why does a Pharma company spend millions to do a clinical trial and does not… https://t.co/OBLkA1QrgB https://t.co/Ykr82lsRRC
-
-
Mashup Score: 149
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 41
A video from Theodore Warkentin (as part of Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024), posted on Mar 19, 2024.
Source: www.vumedi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 140
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 33Low-dose emicizumab prophylaxis in patients with severe hemophilia A: a retrospective study bringing new hope for our patients - 1 month(s) ago
Low-dose emicizumab can potentially offer a cost-effective treatment option in persons with hemophilia A, especially in developing countries.
Source: www.jthjournal.orgCategories: General Medicine News, Hem/OncsTweet
Another one of our papers has been published in the @haemophilia_jnl. It is based on lectures to be given at #WFH2024 next Monday in Madrid on high FVIII/FIX, thrombosis and pain in #hemophilia. Unfortunately PDF also behind a paywall. https://t.co/qy6XHsEdES #thrombosis